Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

451 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Early Application of CPAP in Hematologic

NCT00507533

Conditions: Hematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases
Locations: Università degli Studi Torino Turin, Piedmont, Italy

View Trial Details

Completed

Functional Evaluation of Two Types of Totally Implanted Venous Ports

NCT00484848

Conditions: Hematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: University Hospitals Leuven Leuven, Belgium

View Trial Details

Completed

Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease

NCT00010387

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +28 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Children With Sickle Cell Disease

NCT00004485

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations: Children's Hospital of Oakland Oakland, California, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura

NCT00005652

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns

NCT00004382

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma

NCT00113204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Hackensack University Medical Center The David Jurist Research Center Hackensack, New Jersey, United States

St. Vincent's Comprehensive Cancer Center New York, United States

View Trial Details

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

NCT00001338

Conditions: Agranulocytosis, Body Temperature Changes, Breast Diseases, +19 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

NCT00001839

Conditions: Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Medical Treatment for Diamond Blackfan Anemia

NCT00001749

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +15 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details